PMDA — authorised 18 June 2019
- Marketing authorisation holder: AstraZeneca K.K.
- Status: approved
🇯🇵 Foradil in Japan
PMDA authorised Foradil on 18 June 2019
Marketing authorisation
Foradil in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Cardiovascular approved in Japan
Frequently asked questions
Is Foradil approved in Japan?
Yes. PMDA authorised it on 18 June 2019.
Who is the marketing authorisation holder for Foradil in Japan?
AstraZeneca K.K. holds the Japanese marketing authorisation.